FTC sues Optum Rx, Caremark, and Express Scripts for inflating insulin prices and excluding cheaper options.

The FTC has sued the three largest U.S. pharmacy benefit managers (PBMs)—UnitedHealth's Optum Rx, CVS's Caremark, and Cigna's Express Scripts—accusing them of inflating insulin prices to secure higher rebates from drug manufacturers. The complaint alleges these PBMs exclude cheaper insulin options, harming millions of diabetic patients. This action aligns with the Biden administration's efforts to lower drug costs and increase transparency in pharmaceutical pricing.

September 20, 2024
178 Articles